U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06882681) titled 'Silymarin Bioavailability Study' on March 12.

Brief Summary: This study seeks to evaluate and compare the pharmacokinetics of a novel micellar silymarin formulation with that of a standard silymarin formulation.

Study Start Date: May 01, 2024

Study Type: INTERVENTIONAL

Condition: Bioavailability and Pharmacokinetics

Intervention: DIETARY_SUPPLEMENT: LipoMicel Milk Thistle

A maximum single dose of approx. 140 mg silymarin (in soft gel capsule)

DIETARY_SUPPLEMENT: Unformulated Milk Thistle Extract

A maximum single dose of approx. 130 mg silymarin (in hard gel capsules)

Recruitment Status: COMPLETED

Sponsor: Isura

Publishe...